Logo for Black Diamond Therapeutics Inc

Black Diamond Therapeutics Investor Relations Material

Latest events

Logo for Black Diamond Therapeutics Inc

Study Update

Black Diamond Therapeutics
Logo for Black Diamond Therapeutics

Study Update

23 Sep, 2024
Logo for Black Diamond Therapeutics

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Black Diamond Therapeutics Inc

Access all reports
Black Diamond Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing precision oncology therapies. The company specializes in "MasterKey" therapies, designed to target a broad range of genetically defined tumors. These therapies aim to overcome resistance to treatment, minimize toxicities associated with targeting healthy cells, and penetrate the blood-brain barrier to address central nervous system (CNS) diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.